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Abstract
Background
Lymphatic filariasis (LF) is best known for the disabling and disfiguring clinical conditions
that infected patients can develop; providing care for these individuals is a major goal of the
Global Programme to Eliminate LF. Methods of locating these patients, knowing their true
number and thus providing care for them, remains a challenge for national medical systems,
particularly when the endemic zone is a large urban area.
Methodology/Principle findings
A health community-led door-to-door survey approach using the SMS reporting tool Measur-
eSMS-Morbidity was used to rapidly collate and monitor data on LF patients in real-time
(location, sex, age, clinical condition) in Dar es Salaam, Tanzania. Each stage of the phased
study carried out in the three urban districts of city consisted of a training period, a patient
identification and reporting period, and a data verification period, with refinements to the sys-
tem being made after each phase. A total of 6889 patients were reported (133.6 per 100,000
population), of which 4169 were reported to have hydrocoele (80.9 per 100,000), 2251 lym-
phoedema-elephantiasis (LE) (43.7 per 100,000) and 469 with both conditions (9.1 per
100,000). Kinondoni had the highest number of reported patients in absolute terms (2846,
138.9 per 100,000), followed by Temeke (2550, 157.3 per 100,000) and Ilala (1493, 100.5
per 100,000). The number of hydrocoele patients was almost twice that of LE in all three dis-
tricts. Severe LE patients accounted for approximately a quarter (26.9%) of those reported,
with the number of acute attacks increasing with reported LE severity (1.34 in mild cases,
1.78 in moderate cases, 2.52 in severe). Verification checks supported these findings.
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Conclusions/Significance
This system of identifying, recording and mapping patients affected by LF greatly assists in
planning, locating and prioritising, as well as initiating, appropriate morbidity management
and disability prevention (MMDP) activities. The approach is a feasible framework that could
be used in other large urban environments in the LF endemic areas.
Author summary
Lymphatic filariasis (LF) can cause disabling conditions in infected patients including
lymphoedema-elephantiasis (LE) and hydrocoele. Identifying the number and locations
of these patients is the first step towards ensuring that these patients receive the care they
require, however there is currently no standardised approach for this essential action.
This paper presents a health community-led approach for rapidly identifying patients in
urban areas using an SMS reporting system, MeasureSMS-Morbidity, that allows health
workers to report individual-level patient information (age, sex, location, condition, sever-
ity), which can be then be viewed in real-time via a web browser. The quality of the data
can be easily monitored during the data collection period, and there is instant availability
of patient information. This system is used here in the large urban centre of Dar es Salaam,
Tanzania. A total of 6889 patients were identified, equating to 80.9 hydrocele patients per
100,000 population, 43.7 LE patients per 100,000 people, and 9.1 patients with both condi-
tions. This information is now enabling the national neglected tropical disease (NTD)
program to provide the essential care facilities and training for LF healthcare in locations
in the city where it is most needed.
Introduction
Lymphatic filariasis (LF) is a neglected tropical disease (NTD) that can have a devastating
impact on affected individuals, with clinical symptoms such as acute dermatolymphangioade-
nitis (ADLA, “acute attacks”), lymphoedema and elephantiasis, and hydrocoele, causing
physical, mental and economic distress [1–6]. In recognition of this, the World Health Organi-
zation’s (WHO) Global Programme to Eliminate Lymphatic Filariasis (GPELF) requires that
countries wishing to be recognised as having eliminated LF are required not only to prove that
disease transmission has been interrupted through mass drug administration (MDA), but that
they are also alleviating the suffering of those affected by providing a minimum package of
care to each person with lymphoedema/elephantiasis (LE) and hydrocoele in LF endemic
areas [7]. This package includes (i) surgery for hydrocoele [8,9], (ii) support for episodes of
ADLA [10,11], and (iii) management of LE to prevent disease progression. Countries wishing
to complete the WHO dossier for certification of elimination as a public health problem are
therefore required to firstly estimate the number of patients in endemic areas at the implemen-
tation unit (IU) level, and to provide information on the number of facilities able to provide
the necessary care to these identified patients. Finally, an assessment of the readiness and qual-
ity of the care being provided at these services is also required [12,13].
Patient numbers at the IU level will enable national LF elimination programmes to appro-
priately forecast, plan and manage patient care, and to meet the requirements of the WHO
dossier for programme success. At present, despite great progress towards interrupting
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transmission of disease with 63 of the 73 endemic countries having initiated MDA, only 18 of
these are reported to monitor morbidity management and disability prevention (MMDP) at
this geographical level, i.e. have identified the number of IUs with known cases, or the IUs
where MMDP services are provided [12]. There are currently no specific guidelines on the
methods for obtaining patient estimates, although an MMDP toolkit is currently under devel-
opment by WHO to provide additional guidance for this. Current documented suggestions
include collecting LE and hydrocoele information during LF baseline prevalence surveys,
when enumerating households during MDA, or conducting separate surveys either indepen-
dently or in collaboration with other organizations concerned with similar disabilities and
their care [14]. Many countries are known to collate morbidity information whilst distributing
MDA, however the quality of this information has been shown to be very variable, with
national programmes lacking the necessary resources to validate their data [15,16]. Examples
of bespoke patient enumeration surveys can also be found in the literature, however these tend
to be on a small scale and are labour intensive and as such may be difficult to scale up to the
required geographical level [16,17].
Dar es Salaam is a large and densely populated region on the coast of Tanzania which at the
time of the survey (2015) comprised of three districts: Temeke, Kinondoni and Ilala. In this
region LF is caused by the Wuchereria bancrofti parasite, transmitted by the Culex mosquito.
Previous estimates of LF prevalence in Dar es Salaam measured using immunochromato-
graphic tests (ICTs) includes 9.9% (Temeke = 13.2%, Kinondoni = 14.4%, Ilala = 4.7%), by
Mwingira et al. (2017) [18], and 3.0% by Mwakitalu et al. (2013) [19]. Four rounds of MDA
have been completed in the Dar es Salaam region since 2013, with varying therapeutic cover-
ages due to the challenges associated with administering treatment within a large dynamic
urban population. While it was anticipated that there was likely to be a significant number of
LF clinical cases in Dar es Salaam, there was limited data on the scale of the problem. As such,
there was a relative lack of evidence upon which to plan a suitable MMDP strategy [20].
The primary aim of this study was to improve our knowledge of the overall LF morbidity
burden in Dar es Salaam, and further to gain an understanding of the geographical distribu-
tion of cases to guide the delivery of MMDP services to where they are most needed. Due to
the association between the prevalence of clinical cases and of infection, knowing more about
the locations of cases may also allow programmes to identify areas where MDA should be
more focussed [21]. To undertake this task at this geographical scale in a time-effective man-
ner, we implemented the mHealth short message service (SMS) reporting system, ‘Measur-
eSMS-Morbidity’, which enables the rapid collection, collation and dissemination of estimated
LF patient numbers [22,23]. Prior to this study, MeasureSMS-Morbidity had been imple-
mented in rural areas of Malawi and Ghana, but had yet to be trialled in a densely populated
urban area [22]. The system relies upon a network of local health workers to each collect indi-
vidual-level patient data over small geographical areas which they then submit via SMS using
their own mobile phones. These data are then automatically collated into an online database
which can be accessed and interrogated using a web browser. Mobile technology-driven, com-
munity-led approaches to conducting surveys such as this have proven to increase time effi-
ciency, and consequently cost-efficiency, of data collection whilst further increasing the sense
of local data ownership and accountability [23].
Methods
Ethics statement
LF patient identification and reporting activities are part of routine programme activities con-
ducted by the Ministry of Health and Social Welfare, Tanzania, and as such ethical clearance
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in Tanzania was not required, and a waiver was granted. Oral consent to record and report
details relating to their condition was obtained from all identified LF patients, however this
was not documented. Reported and verified patients were verbally informed of the purpose of
the activity, and all resulting data were analysed anonymously. Data reporters did not record
any information on patients who refused to disclose any information, and those who did not
wish to be examined by the clinical officer were excluded from the verification survey. Ethical
clearance was obtained from the Liverpool School of Tropical Medicine Research Ethics Com-
mittee (Research Protocol 12.22).
Patient identification survey
In order to achieve the primary aim of this study i.e. to assess the LF morbidity burden in Dar
es Salaam, a patient identification survey was undertaken. This survey was undertaken in three
phases between March and August 2015, covering each of Dar es Salaam’s three districts i.e.
Temeke, Kinondoni and Ilala. To undertake this task efficiently with respect to both time and
resources, a health community-led door-to-door survey approach was used and the Measur-
eSMS-Morbidity reporting tool was incorporated to rapidly collate and monitor the data.
Detailed information on the MeasureSMS-Morbidity system can be found elsewhere [22–24].
In brief, this system allows basic information on identified patients such as their location, sex,
and age, plus information on their clinical condition (LE or hydrocoele), severity of LE (mild,
moderate, severe), and number of acute attacks experienced in the last 6 months, to be
recorded by the health community staff and reported via SMS using their own phones. This
information can then be viewed in real-time via a web browser. Each individual SMS report
also generates a SMS response indicating either that the message had been sent in the correct
format, or that there are reporting errors that required correcting. The severity of LE was clas-
sified as either mild = slight swelling, moderate = enlarged limb with shallow folds, and
severe = greatly enlarges limb with deep folds as previously described [22]. These categories
correspond to a Dreyer staging of 1–2 (mild), 3–4 (moderate) and 5+ (severe).
Prior to this current study, the MeasureSMS-Morbidity system had been implemented in
rural settings only, and this was the first time at which the system had been implemented at
such a large scale, and in an urban area. To facilitate this scale up, the implementation process
was revised and refined after each phase. Each phase consisted of a training period, a patient
identification and reporting period and a data verification period. This verification period was
incorporated into the study to address the secondary objective of assessing data quality. Specif-
ically, the verification period enabled the positive predictive value (PPV) of the identified
patients to be estimated i.e. the proportion of patients identified during the survey who were
confirmed to have lymphoedema or hydrocole. Phase 1 (Temeke) was initiated in March 2015,
and Phases 2 (Kinondoni) and 3 (Ilala) was commenced in July and August 2015 respectively.
The initial process and the subsequent refinements are described below.
Training on LF morbidity and the SMS system
Initial process. Patient identification and reporting were undertaken using a two tiered
approach [24]. Frontline health workers (one per facility) were invited to participate in the
activity, during which they were to adopt the role of ‘data reporter’. Data reporters were
required to: (1) train a team of ‘patient identifiers’, usually community health volunteers
(CHVs), in how to identify and advise LE and hydrocoele patients, (2) supervise the patient
identifier whilst they conducted a patient identification survey (3), collate the patient informa-
tion that the patient identifiers record on paper forms at regular intervals throughout the
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survey period and (4) report this patient information by SMS using their own mobile phones,
sending one SMS per identified patient (Fig 1).
Data reporters were provided with mobile phone credit for an allocated number of text
messages for this purpose. The cost of sending an SMS varied according to the network used,
and credit bundle purchased, with at most a single SMS costing $0.02 USD to send. To prepare
them for the activity, the data reporters each attended a half day training session which focused
on recognising and managing/treating LE and hydrocele (the precise information on a
patient’s actual condition to be collected during the patient identification survey), how to use
the paper-based data collection tools, and finally how to submit the relevant patient informa-
tion by SMS using a simple but specific format. A practice exercise was undertaken during
the training session to give each data reporter the opportunity to become familiar with the
required format of the SMS under the supervision of the training team. The training sessions
were also attended by a member of the district-level health team, whose role was to allocate
patient identifiers to each data reporter and to support the overall supervision of the activity.
Refinements. The training process remained largely unchanged throughout the three
phases of survey period. Greater emphasis was placed on common data reporting errors iden-
tified during previous phases, as well as the time allocated to practise sending data via SMS
being increased, particularly for those who were less familiar with sending SMS messages. Fur-
ther, in the second the third implementation phases, if a data reporter was identified as having
extreme difficulty in sending the SMS during the practice sessions e.g. due to poor eyesight, a
replacement data reporter for that facility was identified.
Patient identification and reporting
Initial process. Patient identification was undertaken by CHVs, with each CHV being
allocated a street (a “mtaa”) or part of a street within the vicinity of the health facility where
their supervising data reporter was based. In general, these areas differed from those within
which the CHV usually operated. CHVs were instructed to go door-to-door in their allocated
area and identify individuals within a household with either clinical condition (LE or hydro-
coele), and to record this information on a paper form. Identification was initially achieved
by showing individuals illustrations of LE (mild, moderate and severe) and hydrocoele, and
description using local terms for the conditions. Individuals would then self-report these con-
ditions, after which the CHV would confirm LE and severity through examination; hydrocoele
Fig 1. Flow of patient information during the patient identification exercise conducted in the three districts of Dar es
Salaam.
https://doi.org/10.1371/journal.pntd.0005748.g001
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cases were not confirmed through examination. Following this, the CHV would give basic
MMDP advice to patients. At the end of each day this paper form was given to their designated
data reporter, who transferred the information to a master form, and sent the information in
via SMS. It is during this phase that each identified patient was allocated a unique identifica-
tion number which was used to link the SMS record back to the patient, as patient names were
not contained in the SMS. These SMS reports were monitored in real-time by the supervising
team via the web browser, allowing any reporting errors or inconsistencies to be identified and
rectified.
Refinements. The data collection forms were amended following the first implementation
phase to include the patient’s colloquial or ‘famous’ name, and both the patient’s and the
patient identifier’s phone numbers. This information greatly facilitated patient follow-up as
prior to this follow-up was only possible via the patient identifier. The monitoring process
was also adapted after the first iteration such that clarification was sought if a patient’s age was
reported to be less than 10 years, or if a patient was reported to have both conditions.
Verification of reported patients
Initial process. To assess the quality of the patient identification data, particularly the
accuracy of the reported clinical condition, a follow-up verification survey was conducted after
each patient identification period. The verification team consisted of a clinical officer plus the
original patient identifier where possible, to ensure consistency for the patient. During this
process, patients were provided with additional advice on how to manage their condition and/
or access treatment.
The process used to select patients to verify during the first phase was similar to that used in
previous small-scale rural surveys conducted in Malawi and Ghana, i.e. a (stratified) random
sample of patients were selected and visited by a LF morbidity expert to assess the presence
and severity of the clinical condition. Additional demographic information was also collected
for comparison against that which was reported by SMS. The survey team was provided with
the unique patient ID and the reported sex and condition of the patient only to allow the
remaining patient information (age, severity of condition, number of acute attacks experi-
enced in the last 6 months) to be collected independently from the original SMS report. Verifi-
cation survey sample size calculations were based on the expected positive predictive value
(PPV) i.e. the proportion of identified patients who were confirmed to have their reported
condition [22]. Based on previous surveys we assumed a PPV of 0.9 for lymphoedema and 0.8
for hydrocoele, and the sample size calculation was based on a 95% confidence level and 10%
precision. On completion of the verification survey, the data recorded by the verification team
were compared with that reported by SMS during the patient identification survey. The PPV
for each condition, and overall PPV were then calculated.
Refinements. The initial verification process was determined to be too time consuming
and labour intensive in a densely populated urban environment. Whilst information on the
area in which the patient resided was collected by the patient identifiers, and recorded on the
data reporter’s initial master form, the exact location of the patient was difficult to pinpoint
without the assistance of the patient identifier. As the patient identifier was not always avail-
able during the verification period, this slowed down the patient locating process. Further-
more, following the first phase of patient identification in Temeke, Dar es Salaam was subject
to severe flooding which resulted in difficulties in accessing targeted areas plus population dis-
placement. The addition of the identified patient’s phone number in the data collection sheet
was recognised as one way to alleviate these difficulties. Further, a revised sampling strategy
was also adopted for Phases 2 (Kinondoni) and 3 (Ilala) i.e. a cluster-based sampling strategy
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using the data reporters as clusters. As data reporters were responsible for training the patient
identifiers in recognising LE and hydrocoele it was recognised that there would potentially be
between-cluster variation in PPV, which needed to be accounted for when calculating the
required sample size for a cluster-based verification survey. However, at this time there were
no data available to explore this further and obtain an estimate of the design effect, a conserva-
tive approach was therefore taken, i.e. the sample size was increased by 10% to account for a
moderate amount of between cluster variability. Data reporters were selected randomly, and it
was then the data reporters’ responsibility to select a fixed number of patients from their list to
be examined.
Analysis. Summaries of the cases reported by SMS were produced including the number
and overall incidence of cases by district, age, sex, and severity. Further, ward-level maps of the
reported data were produced, and the mean number of acute attacks within the last 6 months
was explored by severity was calculated. The quality of the reported data was assessed via sum-
maries of the percentage of correctly submitted SMS messages by district over time and
between districts. The significance of the differences in district-level acceptance rates were
assessed using a difference in proportions test. PPV summaries of the verification data were
produced, and Cohen’s kappa was used to determine the level of agreement in the severity of
condition as assessed by the patient identifiers and the verification team.
Results
Reported data
Table 1 presents the number of patients with each condition reported by SMS. In absolute
terms, Kinondoni had the highest number of reported patients (2846) comprised of 950 LE
only patients, 1654 hydrocoele only patients, and 242 with both conditions. This was followed
by Temeke (2550 total, 807 LE, 1560 hydrocoele, 183 with both), then Ilala (1493 total, 494 LE,
955 hydrocoele, 44 with both).
Prevalence estimates (per total population and per male population for hydrocoele) were
calculated using the 2015 population estimates as the denominator, which were extrapolated
from the 2012 census using annual growth rates of 5.8%, 4.9% and 6.5% for Temeke, Kinon-
doni and Ilala respectively, i.e. population estimates of 1,621,148, 2,048,976 and 1,485,308,
totalling 5,155,432, with male population estimates of 707,861, 902,981 and 634,663 totalling
2,245,505 [25]. The overall reported morbidity prevalence for Dar es Salaam was 133.6 per
100,000 total population, with the highest prevalence seen in Temeke (157.3 per 100,000) and
the lowest in Ilala (100.5 per 100,000). This pattern was consistent for both conditions, with LE
only prevalence per 100,000 population ranging from 33.3 in Ilala to 49.8 in Temeke, and
Table 1. Reported lymphoedema-elephantiasis and hydrocoele prevalence for each of Dar es Salaam’s three districts.
Lymphoedema-
Elephantiasis only
Hydrocoele only Both Total
N Prevalence per
100,000 total
population
N Prevalence per 100,000 total
population (per 100,000 male
population)
N Prevalence per
100,000 total
population
N Prevalence per
100,000 total
population
Temeke
(Phase 1)
807 49.8 1560 96.2 (220.4) 183 11.3 2550 157.3
Kinondoni
(Phase 2)
950 46.4 1654 80.7 (183.2) 242 11.8 2846 138.9
Ilala (Phase 3) 494 33.3 955 64.3 (150.5) 44 3.0 1493 100.5
Total 2251 43.7 4169 80.9 (185.7) 469 9.1 6889 133.6
https://doi.org/10.1371/journal.pntd.0005748.t001
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hydrocoele only prevalence per 100,000 males ranging from 150.3 in Ilala to 220.4 in Temeke.
The ratio of LE to hydrocoele patients was consistent across all three districts, with the number
of hydrocoele patients being almost twice that of LE cases.
Table 2 presents summaries of the reported patients by age and sex. District-level popula-
tion data was obtained from the National Bureau of Statistics [26] for 2012, and the totals were
projected to represent 2015 as described above. The prevalence of LE was approximately equal
between males and females in all three districts (Temeke: 64.84 and 71.72 per 100,000 popula-
tion; Kinondoni: 67.89 and 60.37; Ilala 39.86 and 42.84 for males and females, respectively). A
positive relationship was observed between age and LE prevalence in all three districts and
both sexes, with the highest prevalence being observed in the oldest age group in Temeke (>74
years, 708.44 patients per 100,000 population), and in the 60–74 age group in Kinondoni
(474.30 patients per 100,000 population) and Ilala (353.16 per 100,000 population). For hydro-
coele, a similar trend in age was observed (1,075.4 patients per 100,000 population aged>74 in
Temeke, 727.8 patients per 100,000 population aged 60–74 in Kinondoni and 614.2 patients
per 100,000 population aged 60–74 in Ilala).
Table 3 presents summaries of severity of reported LE (mild, moderate, severe) by district,
including the mean and standard deviation of the number of reported number of acute attacks
experienced in the previous six months. Overall, severe LE patients account for approximately
a quarter of those reported (26.9% overall ranging from 25.0% in Temeke to 31.0% in Ilala),
with the number of acute attacks increasing with reported severity (1.34 in mild cases, 1.78 in
moderate cases, 2.52 in severe). The variability in the number of reported attacks also increases
with severity (1.33 in mild cases, 1.62 in moderate, 1.84 in severe). Similar trends are seen in
each of the three districts.
Maps of prevalence by ward level, using extrapolated 2015 population estimates as the
denominator (http://ihi.eprints.org/2168/1/Village_Statistics.pdf) are presented in Fig 2. These
figures highlight the high morbidity prevalence in the southern peri-urban wards of Temeke
and the northern peri-urban wards of Kinondoni.
Accuracy of data
The MeasureSMS-Morbidity system stores every SMS received and automatically checks the
SMS for formatting errors. Table 4 summarises the SMS acceptance rates (% of SMS without
any formatting errors) for each of the three patient identification phases. These error rates
reflect two processes. Firstly, they give an indication of the data reporters’ ability to report data
using the MeasureSMS-Morbidity system, which may in turn reflect improvements in the
training process. Secondly, they reflect the effectiveness of the data supervision process, as the
incoming data were reviewed each day by the supervision team and data reporters were con-
tacted when repeated errors or data inconsistencies were identified. During Phase 1 (Temeke),
data supervision was largely undertaken by the donors whereas phases 2 (Kinondoni)
and 3 (Ilala) was managed by the Ministry of Health staff, with support from the donor. In
comparing the acceptance rates between these three period, no significant differenced were
observed (p = 0.3788). However once duplicates were removed, significant differences were
observed (p<0.001), with a greater proportion of accepted messages being kept in phase 1
(Temeke = 98.5%) in comparison to phases 2 and 3 (Kinondoni = 94.7 and Ilala = 94.0%). Fig
3 presents the acceptance rate by reporting day for each of the three districts. We again observe
slightly higher acceptance rates by day in Phase 1 (Temeke). Table 4 indicates that in each dis-
trict, data were reported over a period of 12–15 days, with most data (greater than 80%) being
sent in the first 7 days of the reporting period. We therefore hypothesise that the decline in
acceptance rates towards the end of the patient identification period seen in Fig 3 is likely due
Lymphatic filariasis patient identification in urban Tanzania
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Table 2. Demographic summaries of reported patients.
Lymphoedema-Elephantiasis (include both conditions) Hydrocoele
Male Female Total Male Total
N Prevalence per
100,000 total
population
N Prevalence per
100,000 total
population
N Prevalence per
100,000 total
population
N Prevalence per 100,000 total
population (per 100,000
males)
Temeke 0–14 1 0.42 5 2.05 6 1.25 23 4.8 (9.7)
15–
29
37 16.39 66 24.40 103 20.76 124 25.0 (54.9)
30–
44
116 73.41 167 111.15 283 91.80 532 172.6 (336.7)
45–
59
138 226.85 148 285.56 286 253.86 521 462.4 (856.4)
60–
74
113 534.94 104 618.50 217 571.97 408 1075.4 (1931.4)
>74 52 917.48 39 543.37 91 708.44 131 1019.8 (2311.3)
NA 2 - 2 4 4
Total 459 64.84 531 71.72 990 68.36 1743 120.3 (246.2)
Kinondoni 0–14 18 6.58 6 2.12 24 4.31 57 10.2 (20.8)
15–
29
66 21.74 52 13.69 118 17.27 165 24.1 (54.3)
30–
44
206 95.25 204 102.19 410 98.58 635 152.7 (293.6)
45–
59
171 224.21 177 263.27 348 242.51 593 413.2 (777.5)
60–
74
122 451.83 110 502.00 232 474.30 356 727.8 (1318.5)
>74 29 474.44 30 400.88 59 433.95 88 647.2 (1439.7)
NA 1 - 0 - 1 2 -
Total 613 67.89 579 60.37 1192 64.02 1896 101.8 (210.0)
Ilala 0–14 3 1.45 1 0.47 4 0.96 25 6.0 (12.1)
15–
29
27 13.42 37 15.04 64 14.31 57 12.7 (28.3)
30–
44
74 50.39 71 52.08 145 51.20 273 96.4 (185.9)
45–
59
79 141.35 89 186.31 168 162.07 365 352.1 (653.1)
60–
74
57 298.15 68 415.20 125 352.16 218 614.2 (1140.3)
>74 13 259.71 19 288.07 32 275.84 61 525.8 (1218.7)
Total 253 39.86 285 42.84 538 41.39 999 76.8 (157.4)
Total 0–14 22 3.07 12 1.62 34 2.34 105 7.2 (14.6)
15–
29
130 17.80 155 17.29 285 17.52 346 21.3 (47.4)
30–
44
396 75.98 442 90.90 838 83.19 1440 142.9 (276.3)
45–
59
388 201.05 414 248.16 802 222.89 1479 411.0 (766.4)
60–
74
292 434.25 282 511.75 574 469.15 982 802.6 (1460.4)
>74 94 560.00 88 413.99 182 478.41 280 736.0 (1668.1)
NA 3 2 5 - 6 -
Total 1325 59.01 1395 58.99 2720 59.00 4638 100.6 (206.5)
https://doi.org/10.1371/journal.pntd.0005748.t002
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to there only being a small number of reports being submitted during this time, with these
data reporters being those who had difficulties using the system.
The length of the verification surveys varied with each phase. Due to adverse flooding
conditions experienced in March and May 2015, the simple (stratified) random sampling
approach used, and the difficulties in locating selected patients as described in the methods
section, the verification process in Temeke lasted over 13 months and was completed in May
2016. Over this period, 38 patients were randomly selected for verification and visited by the
verification team. No issues were observed between paper forms and data sent via SMS when
paper forms were reviewed as the initial part of the verification. When comparing the written
records collected during this verification visit with the initial data reported during the patient
identification survey it was possible to match 36 (15 reported LE, 21 reported hydrocoele) of
the 38 patients by patient ID and gender. Of these 36, the main difference observed were in the
initially reported age and the age reported during verification, with a median difference of two
years. As inconsistencies in age recall is common in these settings, differences of up to 10–15
years were expected. Four matched patients in Temeke had an age difference of greater than
15 years.
Adaptations made to the data collected during patient identification i.e. the inclusion of the
patient’s phone number, plus the refinements made to the sampling process resulted in the
verification for Kinondoni and Ilala being completed much more efficiently. There were how-
ever still some delays due to the transience of the population in Dar es Salaam as well as some
restructuring of the city resulting in large areas of houses being demolished between the time
of patient identification and data verification period. In both Kinondoni and Ilala, 115
patients, reported by 16 data reporters in each district, were verified over a 6 month period. Of
the 115 patients in Kinondoni it was not possible to match 17 patients with the reported data,
hence only 98 verified patients (24 reported LE, 71 reported hydrocoele, 3 reported with both
conditions) were included in the final dataset. The median difference in reported age for these
98 patients was two years, with 10 patients having age differences of greater than 15 years. In
Ilala, only one patient could not be matched, hence 114 patients were included (30 reported
LE, 75 reported hydrocoele, 9 reported with both conditions). The median difference in
Table 3. Reported LE severity and acute attacks summary.
Mild (stage 1–2) Moderate (stage 3–4) Severe (stage 5+) Total
Temeke N 319 260 193 772
% of patients 41.3% 33.7% 25.0% 100%
Mean attacks 1.67 2.06 2.83 1.75
SD attacks 1.51 2.00 2.00 1.89
Kinondoni N 350 325 244 919
% of patients 38.1% 36.5% 26.6% 100%
Mean attacks 1.16 1.71 2.39 1.51
SD attacks 1.08 1.15 1.72 1.50
Ilala N 106 208 141 455
% of patients 23.3% 45.7% 31.0% 100%
Mean attacks 0.99 1.53 2.30 1.45
SD attacks 1.28 1.65 1.78 1.65
Total N 775 793 578 2146
% of patients 36.1% 37.0% 26.9% 100%
Mean attacks 1.34 1.78 2.52 1.58
SD attacks 1.33 1.62 1.84 1.68
https://doi.org/10.1371/journal.pntd.0005748.t003
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reported age of these patients was three years, with 12 patients having age differences greater
than 15 years.
Table 5 presents the verification results by district. Of the 81 patients reported to have either
LE or both conditions, 63 (77.8%) were diagnosed by the verification team as having LE, rang-
ing from 71.8% (28/39) in Ilala to 86.7% (13/15) in Temeke. Of the 179 patients reported to
have hydrocoele or both conditions, 165 (92.2%) were diagnosed as having hydrocoele by the
verification team, ranging from 88.1% (74/84) in Ilala to 95.9% (71/74) in Kinondoni. Similar
Fig 2. (a) Population density at the ward level for 2015 using extrapolated data from 2012 census, and the reported
morbidity prevalence per 100,000 people obtained using the MeasureSMS-Morbidity system (b) overall,(c) for LE and (d) for
hydrocoele.
https://doi.org/10.1371/journal.pntd.0005748.g002
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results were observed after removing the 26 patients whose reported age differed by more than
15 years between the two data sources (S1 Table).
Of the 18 people misdiagnosed with LE, 14 were confirmed to have hydrocoele, whereas 4
had other conditions. Of the 14 people misdiagnosed with hydrocoele, 5 had LE, 1 had a her-
nia, 2 had previously had hydrocoele but had been operated on, 5 had other conditions and 1
did not have any discernible illness. It is also worth noting that of the 165 confirmed to have
hydrocoele, 27 (16.3%) had a concurrent hernia. Twelve patients with both LE and hydrocoele
were included in the verification survey. Only 4 (33.3%) of these were confirmed to have both
conditions, 5 had hydrocoele only, 2 had LE only and 1 had a non-LF associated condition.
Of the 63 patients correctly verified as having LE, 60 had reported the severity of the condi-
tion (11 mild, 26 moderate, 23 severe). In comparing these with the Dreyer score determined
for each patient during the verification process (stage 1–2 = mild, stage 3–4 = moderate, stage
5+ = severe), 3 (27.3%) were correctly verified as mild, 16 (61.5%) were correctly identified as
moderate and 6 (26.1%) were correctly identified as severe (Table 6). Overall, there was low
agreement between the severity assigned by the patient identifiers and the verification team
(Cohen’s kappa = 0.083).
Table 4. Summary of messages received during the patient identification period.
Temeke Kinondoni Ilala
N % N % N %
Number of data reporters 118 148 92
Approximate number of patient identifiers 600 500 400
Number of reporting days 12 - 15 12
SMS received 3126 - 3594 1885 -
SMS received in first 7 days 2980 95.3% 2945 82.9% 1527 81.0%
SMS accepted with no formatting errors 2588 82.8% 3006 83.6% 1588 84.2%
Cleaned SMS reports (after removing duplicates etc.) 2550 98.5% 2846 94.7% 1493 94.0%
https://doi.org/10.1371/journal.pntd.0005748.t004
Fig 3. SMS acceptance rates over the patient identification period by day of reporting for each district.
https://doi.org/10.1371/journal.pntd.0005748.g003
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Discussion
Morbidity burden
With the prevalence of LF cases previously unrecorded, these results indicate a much higher
burden of LE and hydrocoele in Dar es Salaam than anticipated for an urban centre, with 2251
patients reported to have LE, 4169 patients reported to have hydrocoele plus a further 469
patients having both conditions. Whilst it is recognised that there may be some false positives
in these reports, and further that some patients may have been missed from the survey, the ver-
ification survey results give the national LF elimination programme confidence that these
numbers are representative of the true burden. Further to these absolute numbers, the national
programme now also has additional information on the geographical distribution of disease,
with the district of Temeke being the most affected of Dar es Salaam’s three districts with the
larger, less densely populated wards reporting in excess of 500 cases per 100,000 people.
This information is crucial in determining the resources needed to manage the conditions
affecting these patients, and will assist in selection in locations within the urban area within
which care services could be most effectively provided. As with many endemic countries, stra-
tegic partnerships have been developed in Tanzania between the national LF programme and
international donors to address the immense burden of LF clinical disease within the country,
leading to the development of plans to scale up hydrocele surgery throughout 2016. Further,
plans to engage CHVs to provide home-based LE training and care for patients and their care-
givers have already been developed with the region’s NTD and home-based care teams. These
services are intended to be supplementary to the specialist filariasis clinic which has been oper-
ated by the national programme in Dar es Salaam since 2000 [20].
The data obtained in this study will also, in addition to guiding morbidity management
activities, provide an insight into disease transmission within Dar es Salaam which is likely to
aid the management of future MDA campaigns, or perhaps the development of alternative
Table 5. Verification data summaries. Note that the reported lymphoedema-elephantiasis and hydrocoele rows include those who were reported to have
both conditions. The report was considered to be correct if the patient was confirmed to have the reported condition, regardless of whether or not another LF-
related condition was also reported or confirmed.
Temeke Kinondoni Ilala Total
Lymphoedema-Elephantiasis
Reported 15 27 39 81
Correct 13 22 28 63
% Correct 86.7% 81.5% 71.8% 77.8%
Hydroceoele
Reported 21 74 84 179
Correct 20 71 74 165
% Correct 95.2% 95.9% 88.1% 92.2%
https://doi.org/10.1371/journal.pntd.0005748.t005
Table 6. A comparison of reported and verified lymphoedema-elephantiasis severity.
Verified
Mild Moderate Severe Total
Reported Mild 3 8 0 11
Moderate 8 16 2 26
Severe 4 13 6 23
Total 15 37 8 60
https://doi.org/10.1371/journal.pntd.0005748.t006
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transmission breaking strategies such as vector control through improved drainage and Culex
mosquito population reduction e.g. using polystyrene beads [27,28]. Difficulties in conducting
MDA within an urban environment often arise due to the factors such as high population
movement, and the resulting low compliance can result in MDA coverage levels that are inade-
quate to permanently break transmission. It is also not clear to what extent the distribution of
patients reflects the transmission patterns in such a mobile urban population. However, the
additional disease transmission information provided by patient mapping may be useful in
raising awareness across the city in general, targeting potential high risk areas with more inten-
sive community sensitisation campaigns, and/or increasing MDA distribution points to
increase coverage [18,19,29,30]. It is likely that future MDAs will benefit from the active and
successful morbidity management activities, as it has been shown that LE management pro-
grammes can be important for improving increasing MDA coverage [31].
mHealth system for patient identification
In implementing the two-tiered patient identification and reporting process in an iterative
manner, it was possible to refine the process with each phase of implementation. Relocating
patients after the initial patient identification survey proved to be the most challenging aspect
of this approach, with unavoidable contributing factors including adverse weather conditions
and population displacement due to the demolition of many houses. Difficulties also arose due
to the patient identifier being unfamiliar with the area to which they had been assigned. Whilst
this problem lessened over the course of the exercise, primarily through ensuring the national
programme could contact the patient directly by mobile phone, it may be beneficial to con-
sider using locally-based patient identifiers should this exercise be repeated elsewhere. Addi-
tionally, by increasing the emphasis on the staging and severity of LE in the training, the
accuracy of the reported data could be improved, thus providing more accurate information
on the level of services required in any given area.
Despite the implementation challenges, there were many benefits to the patient identifica-
tion and the reporting process adopted for this exercise. Notably, the ability to view and assess
the quality of the patient identification data in real time using the MeasureSMS-Morbidity tool
was a great asset. Enabling information on the morbidity burden to be known almost instan-
taneously, as opposed to having to wait a prolonged period for collation and digitization of the
paper forms, also facilitates the provision of needed care to patients much more efficiently
[20]. By the end of the study, the responsibility of monitoring the real-time data and ensuring
its quality was led by the national programme team themselves, thus empowering the local
teams to manage and control their own success. This approach of promoting the national pro-
gramme to take full ownership of the data and the implementation of the process had the effect
of building valuable data management and health surveillance capacity within the local team
[32,33].
This exercise highlights how crucial patient estimates are for the provision of much needed
care to LF patients and the information obtained greatly assists in planning, locating and prior-
itising, as well and initiating, appropriate MMDP activities. The approach to patient identifica-
tion and reporting presented in this paper provide a feasible framework that could be adopted
in other large urban environments [24], and thereby enable these endemic areas to achieve the
MMDP components of the GPELF [12], or could be adapted to address patient identification
issues for other diseases. The focus should now be to develop and implement strategies to meet
the needs of the patients identified during this exercise, and thus ensuring no patient is left
behind.
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